Improving stroke diagnostics with artificial intelligence
Optimizing Acute Ischemic Stroke Diagnostics Using Artificial Intelligence
This study is testing if using artificial intelligence to analyze brain scans can help doctors find blockages in blood vessels faster and improve treatment for people having a stroke.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Oslo University Hospital Academic / other |
| Locations | 3 sites (Drammen and 2 other locations) |
| Trial ID | NCT05652933 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enhance the care pathway for acute ischemic stroke patients by utilizing advanced artificial intelligence techniques for imaging analysis. It will compare the effectiveness of machine learning-based imaging methods against standard care in detecting vessel occlusions and ischemic lesions. The study will involve multiple centers and will assess the diagnostic accuracy of multiphase CT angiography in identifying eligible patients for thrombectomy. The goal is to ensure that more patients receive timely and appropriate treatment for acute strokes.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with ischemic stroke of any severity who can provide informed consent.
Not a fit: Patients who are not available for follow-up assessments or cannot provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly increase the number of stroke patients receiving timely thrombectomy, improving outcomes and reducing disability.
How similar studies have performed: Other studies have shown promise in using AI for medical imaging, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with ischemic stroke. * All stroke severities and vascular distributions are eligible. * Informed written consent signed by the patient, verbal consent from the patient as witnessed by a non-participating health care person or consent by the signature of the patient's family must be provided before inclusion. Patients for whom no informed consent can be obtained will not be included in the study but will be treated according to standard guidelines. Exclusion Criteria: • Patients not available for follow-up assessments (e.g. non-resident).
Where this trial is running
Drammen and 2 other locations
- Vestre Viken Hospital Trust — Drammen, Norway (Recruiting)
- Oslo University Hospital — Oslo, Norway (Recruiting)
- Østfold Hospital Trust — Sarpsborg, Norway (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.